|
| Display Month: |
|
|
|
|
|
| From: |

|
|
|
| To: |

|
|
|
|
|
|
|
Entry Type:
|
(View Selection)
|
|
|
Entry Category:
|
(View Selection)
|
|
|
IN.gov Category:
|
(View Selection)
|
|
|
|
|
|
Submit
|
|
| |
|
| [FSSA] Medicaid DUR Board Meeting |
|
Entry Description
Indiana Medicaid DUR Board Meeting
Indiana Government Center South
Conference Center Room C
- Approval of Minutes--July 20, 2012 Meeting
- Remarks of the Chair
- Opening Comments--OMPP
- Preferred Drug List Review/Therapeutics Committee Recommendations from the Committee’s August 3, 2012 Meetings to Review the PDL--reference IC 12-15-35-28(a)--Xerox
- Annual Review of OTC Drug Formulary, Recommendations from Therapeutics Committee--Xerox
- Smart PA Presentation - Brilinta
- Utilization Edits—Quarterly Review/Recommendations--Xerox
- Update--Xerox
- New Drugs (Standing Agenda Item)
- Liaison with Other Boards
- Public Comment
- Old Business
- New Business
- + Therapeutics Committee's Decision to Defer Price-Related PDL Status Changes Regarding Lipitor and Ovide, As Necessary, to DUR Board
- Adjourn
|
|
Entry Category: HearingsMeetings |
IN.gov Category: Family & Health |
Agency Name Family and Social Services Administration |
|
|
|